City

Bismarck (1)

Columbus (1)

Grand Forks (1)

Rochester (1)

San Antonio (1)

Scottsdale (1)

Syracuse (1)

Overall Status

Completed (2)

Recruiting (1)

Phase

n/a (2)

phase 2 (1)

Sponsor

Mayo Clinic (1)

National Cancer Institute (NCI) (1)

Ohio State University Comprehensive Cancer Center (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

acetylcysteine (1)

gefitinib (1)

placebo (1)

quality of life assessment (1)

quality-of-life assessment (1)

questionnaire administration (1)

transoral robotic surgery (1)

Study Documents

Intervention Type

drug (2)

other (1)

procedure (1)

Funder Type

Other (2)

NIH (1)

Study Type

Interventional (3)

stage ivb adenoid cystic carcinoma of the oral cavity

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Squamous

Recruiting

Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
+50 more

transoral robotic surgery
quality of life assessment

Columbus, Ohio

Ohio State University Medical Center

Oct 28, 2022

Mucositis, Oral Complications, Recurrent Adenoid Cystic Carcinoma of the Oral Cavity Trial in United States (acetylcysteine, ,

Completed

Has Results

Mucositis
+82 more

acetylcysteine
+3 more

Scottsdale, Arizona
+4 more

Apr 22, 2019

Anaplastic Thyroid Cancer, Insular Thyroid Cancer, Metastatic Parathyroid Cancer Trial in San Antonio (gefitinib)

Completed

Anaplastic Thyroid Cancer
+85 more

gefitinib

San Antonio, Texas

Southwest Oncology Group

Jan 11, 2013